4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-22-011878
Director sold 21,959 shares at $16.15 ($354,638)
- Director acquired 21,959 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Quart Barry D Director | 2022-11-29 | Option exercise | +21,959 | $1.59 | $34,915 | 21,959 | D |
| Quart Barry D Director | 2022-11-29 | Sale | −21,959 | $16.15 | $354,638 | 0 | D |
| Derivatives | |||||||
| Quart Barry D Director | 2022-11-29 | Option exercise · Share Option | −21,959 | 0 | D | ||
| Open-market sales · 21,959 sh · avg $16.15 · $354,638 | |||||||
Loading xslF345X03/form4-12012022_091249.xml…